1. Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Phase 2b Dose-Response Study 
Christopher R. Chapple, Jerzy Lorenz, Raymond Mortensen, Harald Pauthner, Mario O. Reis, Claude C. Schulman, Ingrid van der Putten-Slob 
European Urology Supplements 
Volume 4, Issue 2, Pages (February 2005)
DOI: /j.eursup
Copyright © 2004 Elsevier B.V. Terms and Conditions

2. Fig. 1
Flow diagram of the number of patients enrolled, randomised and completing the study per treatment group.
European Urology Supplements 2005 4, 25-32DOI: ( /j.eursup )
Copyright © 2004 Elsevier B.V. Terms and Conditions

3. Fig. 2
Mean change in total I-PSS from baseline to endpoint (ITT). p-value for mean difference between tamsulosin OCAS and placebo.
European Urology Supplements 2005 4, 25-32DOI: ( /j.eursup )
Copyright © 2004 Elsevier B.V. Terms and Conditions

4. Fig. 3 Effect of treatment on mean total I-PSS over time (ITT).
European Urology Supplements 2005 4, 25-32DOI: ( /j.eursup )
Copyright © 2004 Elsevier B.V. Terms and Conditions